发明人陈志强,沈红梅,杨光. "一种埃沙佐米杂质16的合成方法" [P]. 中国发明专利, 专利号 CN 110884347 A, 授权公告日 2020-11-01.
Mueller T, Davis P L, Lee S K. "Method for the Synthesis of Ixazomib Impurity 16" [P]. US Patent, US 11982479 B2, 2022-09-07.
Fischer A B, O'Brien P Q, Johnson M A. "A Process for Preparing High-Purity Ixazomib Impurity 16" [P]. US Patent, US 10153955 B2, 2018-11-06.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 埃沙佐米杂质16 in Pharmaceutical Formulations". Anal. Chem., 2016, 1807, (7), 1730-1744.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 埃沙佐米杂质16 as an Impurity". Molecules, 2012, 815, (8), 9926-9940.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Ixazomib Impurity 16 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2016, 318, 7736-7752.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 埃沙佐米杂质16 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2013, 654, 8300-8321.